SCHEMBL16280975

SCHEMBL16280975

CNC(=O)CCOCCOCCOCCOCCOCCC(=O)NC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
MCL1 Q07820 1/20 0.37
POLB P06746 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 5/20 0.33
ALDH1A1 P00352 4/20 0.33
MAPT P10636 1/20 0.33
GAA P10253 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CYP2D6 P10635 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRNB2 P17787 1/20 0.32
NFKB1 P19838 1/20 0.32
CHRM3 P20309 1/20 0.32
MAPK1 P28482 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27347790 1.00 LMNA (0.48) LMNAMCL1POLBMEN1KMT2A
SCHEMBL22787027 0.97 LMNA (0.50) LMNAMCL1POLBMEN1KMT2A
SCHEMBL15082734 0.91 ALDH1A1 (0.45) LMNAMCL1POLBKMT2ATSHR
SCHEMBL13449837 0.91 LMNA (0.41) LMNAMCL1POLBMEN1KMT2A
SCHEMBL15763876 0.91 ALDH1A1 (0.45) LMNAMCL1POLBKMT2ATSHR
SCHEMBL24408071 0.91 LMNA (0.41) LMNAMCL1POLBMEN1KMT2A
SCHEMBL16298991 0.91 LMNA (0.41) LMNAMCL1POLBMEN1KMT2A
SCHEMBL22266339 0.91 MEN1 (0.48) LMNAMCL1POLBMEN1KMT2A
SCHEMBL24285433 0.91 LMNA (0.41) LMNAMCL1POLBMEN1KMT2A
SCHEMBL13598106 0.91 LMNA (0.41) LMNAMCL1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012603-B2 Peptides that block the binding of IgG to FcRn BIOGEN IDEC HEMOPHILIA INC. (US) 2015-04-21 US disclosed
US-8906844-B2 Immunomodulatory peptides BIOGEN IDEC HEMOPHILIA INC. (US) 2014-12-09 US disclosed